Biobot Analytics
PrivateLast Round
VC Round
Jun 18, 2025
Est. Valuation
$1.71M
Total Funding Raised
$30.13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Biobot Analytics operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a VC Round in June 2025.
Biobot Analytics is a biotechnology and data analytics company that specializes in wastewater-based epidemiology to provide population-level health intelligence.
Sector
Healthcare & Life Sciences
Verticals
Environmental Monitoring, Healthcare Analytics, Biotechnology, Data Visualization
Business Model
B2G
Customer Profile
Data as a Service, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biobot Analytics Comparables
Compare Biobot Analytics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GT Molecular, Inc. | 86% | |
| Alphabet Inc. | 80% | |
| Resistomap | 77% |
For institutional investors. Book with your work email.
Biobot Analytics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 18, 2025 | ||||
| Grant | Sep 21, 2023 | ||||
| Series A | Oct 22, 2021 | ||||
| Seed | Apr 21, 2020 | ||||
| Seed | May 8, 2018 | ||||
Accelerator | Jan 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Biobot Analytics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Refactor Capital | Seed |
| National Institute on Drug Abuse | Grant |
| The Engine | Series A, Seed |
| Engine Ventures | Seed |
| Hyperplane | VC Round |
| Atreides Management | VC Round |
| Plum Alley Investments | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 58% MoM, reaching 8.5K.
- Apr 26, 2026
Added The Union Shopper Inc. as a customer.
For institutional investors. Book with your work email.
Biobot Analytics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biobot Analytics's valuation, stock price, and market status.
Is Biobot Analytics a public or private company?
Biobot Analytics is a private company.
What is the current stock price of Biobot Analytics?
Biobot Analytics is a private company, so its shares have no public market price. Caplight tracks Biobot Analytics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biobot Analytics worth (valuation)?
Biobot Analytics's valuation is estimated at $1.7M based on funding round data.
Can I buy Biobot Analytics stock?
Biobot Analytics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biobot Analytics's last funding round?
Biobot Analytics's most recent funding round was VC Round on June 18, 2025.
Who are the main investors in Biobot Analytics?
Key investors in Biobot Analytics include The Engine, Engine Ventures, Engine Ventures, Valor Equity Partners, Ekistic Ventures.
Will Biobot Analytics IPO soon?
No public IPO plans have been announced for Biobot Analytics.
How can I track Biobot Analytics secondary market activity?
Caplight tracks bids, offers, and trades in Biobot Analytics's shares on secondary markets.